ReviewFrontiers in pharmacology2021

Effect of Liraglutide on Cardiometabolic Risk Profile in People with Coronary Artery Disease with or without Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Peyman Nowrouzi-Sohrabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.